PI
TEVA icon

Putnam Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Putnam Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-29,599
Closed -$464K – 943
2019
Q1 		$464K Hold
29,599
– – ﹤0.01% 799
2018
Q4 		$456K Buy
+29,599
New +$607K ﹤0.01% 830
2017
Q2 		– Sell
-2,542,800
Closed -$81.6M – 1284
2017
Q1 		$81.6M Sell
2,542,800
-1,415,017
-36% -$48.3M 0.19% 131
2016
Q4 		$143M Sell
3,957,817
-832,450
-17% -$33.2M 0.35% 80
2016
Q3 		$220M Buy
4,790,267
+24,346
+0.5% +$1.27M 0.53% 47
2016
Q2 		$239M Sell
4,765,921
-1,126,881
-19% -$60M 0.58% 41
2016
Q1 		$315M Sell
5,892,802
-1,082,735
-16% -$63.5M 0.75% 25
2015
Q4 		$458M Buy
6,975,537
+238,750
+4% +$14.8M 1.03% 17
2015
Q3 		$380M Sell
6,736,787
-320,060
-5% -$20.8M 0.85% 21
2015
Q2 		$417M Buy
7,056,847
+1,915,309
+37% +$118M 0.84% 22
2015
Q1 		$320M Buy
5,141,538
+4,246,777
+475% +$247M 0.64% 29
2014
Q4 		$51.5M Sell
894,761
-33,910
-4% -$1.89M 0.11% 202
2014
Q3 		$49.9M Sell
928,671
-300,120
-24% -$15.9M 0.11% 187
2014
Q2 		$64.4M Sell
1,228,791
-1,173,667
-49% -$60M 0.14% 157
2014
Q1 		$127M Sell
2,402,458
-1,016,613
-30% -$47M 0.29% 87
2013
Q4 		$137M Buy
3,419,071
+872,762
+34% +$34.4M 0.33% 77
2013
Q3 		$96.2M Buy
2,546,309
+1,612,816
+173% +$62.9M 0.26% 105
2013
Q2 		$36.6M Buy
+933,493
New +$36.4M 0.11% 207

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Putnam Investments's TEVA Position: Q2 2019 in Review

Putnam Investments sold out of Teva Pharmaceuticals (TEVA) in Q2 2019, closing a stake of 29,599 shares — an estimated $464K sold.

Putnam Investments first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $458M in Q4 2015. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

  • Putnam Investments reported no remaining Teva Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Putnam Investments sold 29,599 Teva Pharmaceuticals shares in Q2 2019, an estimated $464K.
  • Putnam Investments first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Putnam Investments's Teva Pharmaceuticals position peaked at $458M in Q4 2015.
  • 452 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2019.

Based on Putnam Investments's 13F filing for Q2 2019, filed 14 Aug 2019.